Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Tuberculosis
99%
Active Tuberculosis
29%
Bacillus
28%
Latent Tuberculosis Infection
25%
Lung
25%
Mycobacterium Tuberculosis Infection
19%
Vaccination
19%
Immune Response
17%
Bacillary Load
17%
Murine Model
15%
Tuberculosis Vaccine
15%
Granuloma
14%
Aerosol
14%
Spain
12%
Reinfection
11%
Foamy Macrophages
11%
Pulmonary Tuberculosis
11%
Bacillary
11%
In Vivo murine Model
11%
Therapeutic Vaccine
10%
Necrosis
10%
Mycobacterium
9%
Clinical Trials
9%
Chemotherapy
9%
Inflammatory Response
9%
COVID-19
9%
Macrophages
8%
Virulence
8%
Human Tuberculosis
8%
Mouse Model
7%
Drosophila Melanogaster
7%
Active Disease
7%
T Cells
7%
Guinea pig
7%
Tuberculosis Infection
7%
Respiratory Specimens
7%
Mycobacterial Infection
6%
Direct Detection
6%
Tuberculosis Bacilli
6%
Mouse Strain
6%
Humoral Response
6%
Immunogenicity
6%
Non-respiratory
6%
Immune System
6%
SARS-CoV-2 Variants
5%
Heat-killed
5%
European Countries
5%
Tuberculosis Treatment
5%
Tuberculin
5%
Immunology and Microbiology
Mycobacterium Tuberculosis
86%
Macrophage
27%
Granuloma
24%
Immune Response
23%
Mycobacterium Bovis BCG
16%
Low Drug Dose
15%
Experimental Model
15%
Immunology
15%
Mycobacteria
13%
BCG Vaccine
13%
Inflammation Response
13%
Dynamics
12%
T Cell
11%
Cytokine
10%
Drosophila Melanogaster
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Immunity
9%
Human Immunodeficiency Virus
9%
C3HeB/Fe Mouse
8%
Colony Forming Unit S
8%
Innate Immune System
8%
Humoral Immunity
7%
Murine
7%
Immunotherapy
7%
Lymph Node
7%
Mouse Model
6%
Human Immunodeficiency Virus 1
6%
Colony-Forming Unit
6%
Infectious Agent
6%
Splenocyte
6%
Tumor Necrosis Factor
6%
Guinea Pig
6%
Mycobacterium vaccae
5%
Regulatory T Cell
5%
Interferon Type I
5%
Interferon Gamma
5%
Neutrophil Granulocyte
5%
Liquid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
58%
Tuberculosis
51%
Infection
47%
Disease
28%
BCG Vaccine
20%
Latent Tuberculosis
18%
Clinical Trial
16%
Chemotherapy
13%
Tuberculin
12%
Isoniazid
11%
Therapeutic Vaccine
11%
Reinfection
10%
Inflammation
9%
Mycobacterium Bovis BCG
8%
Granuloma
8%
Immunotherapy
7%
Placebo
7%
Mycobacteria
6%
Murine
6%
Mouse Model
6%
Necrosis
6%
Messenger RNA
5%
Immunogenicity
5%